News

1 to 9 of 22 results

Sepsis-specific treatment market set to grow to $354 million in 2021; report

26-03-2015

Following the first sepsis-specific product launch in 2016, the treatment market will expand at a compound…

Antibiotics and Infectious diseasesART-123Asahi Kasei PharmaEli LillyEuropeMarkets & MarketingPharmaceuticalUSAXigris

European Commission approves Actavis’ Xydalba

02-03-2015

The European Commission has granted Ireland-headquartered Actavis' subsidiary Durata Therapeutics International…

ActavisAngeliniAntibiotics and Infectious diseasesDalvanceDermatologicalsDurata TherapeuticsEuropePharmaceuticalXydalba

More EMA/CHMP recommendations

23-01-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval…

Anti-viralsAntibiotics and Infectious diseasesCubistDutrebisEuropeIkervisMerck & CoOphthalmicsPharmaceuticalSanten PharmaceuticalsSivextro

Urgent action needed to address Clostridium difficile infections in Europe

Urgent action needed to address Clostridium difficile infections in Europe

03-12-2014

Urgent action is needed to address the current issues relating to the management of health care-acquired…

Antibiotics and Infectious diseasesEuropeEuropean ParliamentPharmaceuticalPolitics

Opportunity to promote good antibiotics prescription practices, says EGA

19-11-2014

The European Generic medicines Association (EGA) used the platform of European Antibiotic Awareness Day…

Antibiotics and Infectious diseasesEuropeGenericsMarkets & MarketingPricing

EMA completes review of polymyxins and issues updated guidance

EMA completes review of polymyxins and issues updated guidance

24-10-2014

The European Medicines Agency has completed its review of polymyxin-based medicines and issued its recommendations…

Antibiotics and Infectious diseasesColistimethateEuropePharmaceuticalRegulation

Janssen commits $200 million to speeding up Ebola vaccine development and increasing production

Janssen commits $200 million to speeding up Ebola vaccine development and increasing production

22-10-2014

US health care giant Johnson & Johnson is to commit up to $200 million to accelerate and expand the production…

Antibiotics and Infectious diseasesBavarian NordicBiotechnologyEuropeJanssenResearch

1 to 9 of 22 results

Back to top